The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Zanidatamab (zani), a HER2-targeted bispecific antibody, in combination with docetaxel as first-line therapy (1L) for patients (pts) with advanced HER2-positive breast cancer (BC): Updated results from a phase Ib/II study.
 
Xiaojia Wang
No Relationships to Disclose
 
Keun Seok Lee
Consulting or Advisory Role - Bixink; Everest Medicine; Lilly; Novartis; Pfizer; Roche
Research Funding - Dong-A ST (Inst)
 
Xiaohua Zeng
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose
 
Kun Wang
No Relationships to Disclose
 
Huiyan Li
Employment - BeiGene Shanghai
Stock and Other Ownership Interests - BeiGene Shanghai
Travel, Accommodations, Expenses - BeiGene Shanghai
 
Ping Zhou
Employment - BeiGene Shanghai
Stock and Other Ownership Interests - BeiGene
 
Yuanyuan Bao
Employment - BeiGene Shanghai
Stock and Other Ownership Interests - BeiGene
 
Zefei Jiang
No Relationships to Disclose